Feeds:
Posts
Comments

Posts Tagged ‘advanced prostate cancer’

BLOOMBERG BUSINESSWEEK: A US company will next month report the results of its study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer, also called castration-resistant prostate cancer. READ MORE>

Read Full Post »

MARKETWIRE:  The approval of Dendreon’s prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity. READ MORE>

Read Full Post »

VANCOUVER SUN: Vancouver researchers have developed a new cancer-fighting drug that will prolong the life of patients with advanced prostate cancer, doubling their life expectancy compared with a decade ago. READ MORE>

Read Full Post »

URO TODAY: A drug originally developed to treat asthma, Tranilast, may improve the prognosis of patients with advanced prostate cancer, a Japanese study has shown. READ MORE>

Read Full Post »

KANSASCITY.COM:  Researchers can cite anecdotes of cancer patients given months to live who have survived 15 years or longer after receiving vaccines, but so far conclusive evidence from large clinical trials is scant. READ MORE>

Read Full Post »

URO TODAY:  The attention-deficit hyperactivity disorder drug Methylphenidate is effective in treating fatigue in men with prostate cancer,but  oncologists need to monitor for possible pulse and blood pressure elevations. READ MORE>

Read Full Post »

BUSINESSWIRE: The results of phase 2 (there are three) trials of a new drug that reduces testosterone to castrate levels and serum free testosterone to levels lower than orchiectomy or LHRH analogs – without bone loss or hot flashes- are about to be reported in the US. READ MORE>

Read Full Post »

Older Posts »